| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | — | +1982.7% |
| R&D Expense | $43.7M | — | +59.2% |
| SG&A Expense | $20.8M | — | +40.5% |
| Operating Income | -$66.4M | — | -57.3% |
| Net Income | -$60.2M | — | -74.7% |
| EPS (Basic) | -$0.71 | — | -57.8% |
| EPS (Diluted) | -$0.71 | — | -57.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.7M | +3.7% | -18.7% |
| Short-term Investments | $1.04B | +46.9% | +61.1% |
| Accounts Receivable | $1.3M | +85.3% | +269.6% |
| Inventory | $1.5M | -4.6% | — |
| Current Assets | $1.10B | +45.1% | +57.2% |
| Total Assets | $1.14B | +43.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$56.9M | — | -94.5% |
| Capital Expenditures | $304K | — | +1800.0% |
| Investing Cash Flow | -$334.8M | — | -79.3% |
| Financing Cash Flow | $393.0M | — | — |
| Free Cash Flow | -$57.2M | — | -95.4% |
| +55.9% |
| Current Liabilities | $35.2M | +14.2% | +55.5% |
| Long-term Debt | $3.0M | +0.0% | — |
| Total Liabilities | $43.5M | +11.5% | +85.6% |
| Stockholders' Equity | $1.09B | +45.1% | +54.9% |